bluebird bio, Inc. 4
4 · bluebird bio, Inc. · Filed Jan 31, 2017
Insider Transaction Report
Form 4
Mandell James
Director
Transactions
- Exercise/Conversion
Common Stock
2017-01-27$21.43/sh+5,000$107,150→ 6,000 total - Exercise/Conversion
Stock Option (right to buy)
2017-01-27+5,000→ 12,000 totalExercise: $21.43Exp: 2024-01-08→ Common Stock (5,000 underlying) - Sale
Common Stock
2017-01-27$70.10/sh−5,000$350,499→ 1,000 total
Footnotes (3)
- [F1]This sales reported in the Form 4 were effectd pursuant to a 10b5-1 trading plan adopted by the reporting person on December 13, 2016.
- [F2]The range in prices for the transaction reported on this line was $70.00 to $70.30. The average weighted price was $70.0998. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]This option vests ratably over three years in annual installments, commencing on January 8, 2014.